Sandford D Smith insider trades: Cytokinetics (CYTK) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sandford reports to the SEC
and 2 more companies
Open-market buys and sales
34 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | CYTK | ↓ Sell | 11,369 | $53.97 | $614K | Direct | Sep 2, 2022 (0d) |
| Dec 27, 2021 | CYTK | ↓ Sell | 28,290 | $45.79 | $1.3M | Direct | Dec 28, 2021 (1d) |
| Nov 19, 2021 | CYTK | ↓ Sell | 29,032 | $41.21 | $1.2M | Direct | Nov 19, 2021 (0d) |
| Jul 19, 2021 | CYTK | ↓ Sell | 11,965 | $28.87 | $345K | Direct | Jul 21, 2021 (2d) |
| Apr 27, 2021 | CYTK | ↓ Sell | 9,739 | $27.76 | $270K | Direct | Apr 27, 2021 (0d) |
| Apr 26, 2021 | CYTK | ↓ Sell | 5,000 | $27.00 | $135K | Direct | Apr 27, 2021 (1d) |
| Apr 23, 2021 | CYTK | ↓ Sell | 5,000 | $26.50 | $133K | Direct | Apr 23, 2021 (0d) |
| Apr 15, 2021 | CYTK | ↓ Sell | 10,714 | $25.23 | $270K | Direct | Apr 15, 2021 (0d) |
| Apr 9, 2021 | CYTK | ↓ Sell | 27,582 | $23.93 | $660K | Direct | Apr 12, 2021 (3d) |
| Oct 5, 2020 | CYTK | ↓ Sell | 5,936 | $30.00 | $178K | Direct | Oct 5, 2020 (0d) |
| Jul 15, 2020 | CYTK | ↓ Sell | 6,667 | $29.00 | $193K | Direct | Jul 17, 2020 (2d) |
| Jul 10, 2020 | CYTK | ↓ Sell | 6,667 | $28.00 | $187K | Direct | Jul 13, 2020 (3d) |
| Jul 8, 2020 | CYTK | ↓ Sell | 13,176 | $26.51 | $349K | Direct | Jul 9, 2020 (1d) |
| Jun 22, 2020 | CYTK | ↓ Sell | 10,000 | $24.50 | $245K | Direct | Jun 22, 2020 (0d) |
| Jun 17, 2020 | CYTK | ↓ Sell | 6,907 | $23.00 | $159K | Direct | Jun 17, 2020 (0d) |
| Jun 15, 2020 | CYTK | ↓ Sell | 6,666 | $22.00 | $147K | Direct | Jun 15, 2020 (0d) |
| Jun 12, 2020 | CYTK | ↓ Sell | 15,045 | $20.86 | $314K | Direct | Jun 12, 2020 (0d) |
| Oct 23, 2014 | APRI | ↑ Buy | 26,500 | $1.57 | $42K | Direct | Oct 24, 2014 (1d) |
| Oct 29, 2013 | AEGR | ↓ Sell | 2,502 | $95.00 | $238K | Direct | Oct 31, 2013 (2d) |
| Aug 12, 2013 | AEGR | ↓ Sell | 10,000 | $92.32 | $923K | Direct | Aug 13, 2013 (1d) |
| Jul 23, 2010 | GENZ | ↓ Sell | 32,041 | $64.41 | $2.1M | Direct | Jul 27, 2010 (4d) |
| May 25, 2010 | GENZ | ↓ Sell | 8,887 | $45.61 | $405K | Direct | May 26, 2010 (1d) |
| May 24, 2010 | GENZ | ↓ Sell | 1,525 | $48.93 | $75K | Direct | May 25, 2010 (1d) |
| Mar 19, 2010 | GENZ | ↓ Sell | 3,359 | $58.90 | $198K | Direct | Mar 23, 2010 (4d) |
| May 26, 2009 | GENZ | ↓ Sell | 1,641 | $56.54 | $93K | Direct | May 27, 2009 (1d) |
| Jan 16, 2008 | GENZ | ↓ Sell | 20,181 | $79.70 | $1.6M | Direct | Jan 18, 2008 (2d) |
| Jan 11, 2008 | GENZ | ↓ Sell | 4,719 | $79.70 | $376K | Direct | Jan 15, 2008 (4d) |
| Jan 9, 2008 | GENZ | ↓ Sell | 100 | $79.70 | $8K | Direct | Jan 11, 2008 (2d) |
| Oct 15, 2007 | GENZ | ↓ Sell | 25,000 | $74.77 | $1.9M | Direct | Oct 17, 2007 (2d) |
| Oct 10, 2007 | GENZ | ↓ Sell | 25,000 | $69.80 | $1.7M | Direct | Oct 12, 2007 (2d) |
| Aug 31, 2006 | GENZ | ↓ Sell | 11,145 | $66.23 | $738K | Direct | Sep 5, 2006 (5d) |
| Mar 1, 2006 | GENZ | ↓ Sell | 12,500 | $69.12 | $864K | Direct | Mar 3, 2006 (2d) |
| Sep 12, 2005 | GENZ | ↓ Sell | 14,220 | $72.41 | $1.0M | Direct | Sep 13, 2005 (1d) |
| Jul 29, 2005 | GENZ | ↓ Sell | 1,118 | $71.76 | $80K | By 401(k) | Aug 25, 2005 (27d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CYTK insiders
Open-market trades in the last 12 months
About Sandford D Smith's insider trades
Sandford D Smith is a director at Cytokinetics (CYTK). Since Jul 29, 2005, Sandford has reported 1 open-market purchase worth $42K and 33 sales worth $19.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (71 filings), option exercises (37 filings), shares returned to the company (3 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.